George K Ng, the Chief Executive Officer of $PCSA, bought 87,200 shares of the company on 01-27-2025 for an estimated $69,542. This trade was reported by Quiver ...

Processa Pharmaceuticals Inc (NASDAQ:PCSA) shares are trading higher by 1198% to 66 cents Tuesday morning after announcing a binding term sheet with Intact Therapeutics Inc. What To Know: The ...

$PCSA insiders have traded $PCSA stock on the open market 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales. Here’s a ...

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) is among the fundamentally strong penny stocks to invest in. Analysts at H.C. Wainwright have reiterated their Buy rating on Processa Pharmaceuticals, Inc.

Processa Pharma (NASDAQ:PCSA) just reported results for the second quarter of 2024. Processa Pharma reported earnings per share of -$1.01. This was below the analyst estimate for EPS of -98 cents. The ...

We recently published a list of 10 Cheapest Stocks Insiders Are Buying Recently. In this article, we are going to take a look at where Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) stands against the ...